Thomson Medical Group Limited (SGX:A50)
Singapore
· Delayed Price · Currency is SGD 0.0440
0.00 (0.00%)
Feb 21, 2025, 9:00 AM SGT
Thomson Medical Group Income Statement
Financials in millions SGD. Fiscal year is July - June.
Millions SGD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Operating Revenue | 382.1 | 351.15 | 355.77 | 333.71 | 240.4 | 216.13 | Upgrade
|
| Other Revenue | 4.71 | 4.83 | 4.79 | 4.79 | - | - | Upgrade
|
| Revenue | 386.81 | 355.98 | 360.56 | 338.5 | 240.4 | 216.13 | Upgrade
|
| Revenue Growth (YoY) | 11.99% | -1.27% | 6.52% | 40.81% | 11.23% | -5.96% | Upgrade
|
| Cost of Revenue | 223.11 | 196.99 | 177.35 | 163.24 | 124.38 | 115.05 | Upgrade
|
| Gross Profit | 163.7 | 159 | 183.21 | 175.26 | 116.02 | 101.08 | Upgrade
|
| Other Operating Expenses | 86.05 | 82.1 | 79.88 | 65.52 | 49.25 | 53.59 | Upgrade
|
| Operating Expenses | 121.54 | 109.56 | 100.95 | 83.45 | 67.2 | 71.84 | Upgrade
|
| Operating Income | 42.16 | 49.44 | 82.26 | 91.81 | 48.81 | 29.24 | Upgrade
|
| Interest Expense | -61.78 | -51.55 | -30.51 | -23.5 | -23.61 | -25.95 | Upgrade
|
| Interest & Investment Income | 4.43 | 7.38 | 3.95 | 0.99 | 0.98 | 2.56 | Upgrade
|
| Earnings From Equity Investments | -0.54 | -0.19 | -0.49 | - | - | - | Upgrade
|
| EBT Excluding Unusual Items | -15.73 | 5.07 | 55.2 | 69.3 | 26.18 | 5.86 | Upgrade
|
| Asset Writedown | 25.53 | 25.53 | - | - | - | -93.4 | Upgrade
|
| Pretax Income | 9.81 | 30.6 | 55.2 | 69.3 | 26.18 | -87.54 | Upgrade
|
| Income Tax Expense | 7.85 | 11.11 | 14.15 | 10.71 | 9.27 | 10.48 | Upgrade
|
| Earnings From Continuing Operations | 1.96 | 19.49 | 41.06 | 58.59 | 16.91 | -98.02 | Upgrade
|
| Net Income to Company | 1.96 | 19.49 | 41.06 | 58.59 | 16.91 | -98.02 | Upgrade
|
| Minority Interest in Earnings | -1.44 | -4.06 | -4.5 | -4.82 | -2.67 | -1.42 | Upgrade
|
| Net Income | 0.52 | 15.44 | 36.56 | 53.76 | 14.24 | -99.44 | Upgrade
|
| Net Income to Common | 0.52 | 15.44 | 36.56 | 53.76 | 14.24 | -99.44 | Upgrade
|
| Net Income Growth | -96.72% | -57.78% | -32.01% | 277.62% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 26,441 | 26,441 | 26,441 | 26,441 | 26,441 | 26,441 | Upgrade
|
| Shares Outstanding (Diluted) | 26,459 | 26,459 | 26,447 | 26,441 | 26,441 | 26,441 | Upgrade
|
| Shares Change (YoY) | 0.01% | 0.05% | 0.02% | 0.00% | 0.00% | 0.34% | Upgrade
|
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
| EPS Growth | -98.49% | -57.94% | -32.04% | 277.14% | - | - | Upgrade
|
| Free Cash Flow | -50.47 | 56.49 | 77.39 | 65.05 | 23.96 | -1.4 | Upgrade
|
| Free Cash Flow Per Share | -0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 | Upgrade
|
| Dividend Per Share | - | - | 0.000 | - | - | - | Upgrade
|
| Gross Margin | 42.32% | 44.66% | 50.81% | 51.78% | 48.26% | 46.77% | Upgrade
|
| Operating Margin | 10.90% | 13.89% | 22.81% | 27.12% | 20.30% | 13.53% | Upgrade
|
| Profit Margin | 0.13% | 4.34% | 10.14% | 15.88% | 5.92% | -46.01% | Upgrade
|
| Free Cash Flow Margin | -13.05% | 15.87% | 21.46% | 19.22% | 9.97% | -0.65% | Upgrade
|
| EBITDA | 66.18 | 67.11 | 95.42 | 102.95 | 59.54 | 47.49 | Upgrade
|
| EBITDA Margin | 17.11% | 18.85% | 26.46% | 30.41% | 24.77% | 21.97% | Upgrade
|
| D&A For EBITDA | 24.02 | 17.67 | 13.16 | 11.14 | 10.73 | 18.25 | Upgrade
|
| EBIT | 42.16 | 49.44 | 82.26 | 91.81 | 48.81 | 29.24 | Upgrade
|
| EBIT Margin | 10.90% | 13.89% | 22.81% | 27.12% | 20.30% | 13.53% | Upgrade
|
| Effective Tax Rate | 80.03% | 36.30% | 25.63% | 15.46% | 35.41% | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.